Glaukos Corporation (GKOS)
NYSE: GKOS · Real-Time Price · USD
178.27
-0.61 (-0.34%)
Oct 26, 2026, 4:00 PM EDT - Market closed
Glaukos Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 612.84 | 507.44 | 383.48 | 314.71 | 282.86 | 294.01 |
Revenue Growth | 41.55% | 32.32% | 21.85% | 11.26% | -3.79% | 30.70% |
Gross Profit Gross Profit Growth | 484.88 | 395.63 | 289.45 | 239.14 | 213.88 | 227.38 |
Operating Income Operating Income Growth | -78.99 | -86.73 | -108.14 | -123.7 | -102.31 | -52.87 |
Net Income Net Income Growth | -188.05 | -187.69 | -146.37 | -134.66 | -99.2 | -49.59 |
Earnings Per Share EPS Growth | -3.25 | -3.28 | -2.77 | -2.78 | -2.09 | -1.07 |
EPS Growth | - | - | - | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Glaucoma Glaucoma Growth | 513.84 | 421.07 | 303.28 | 237.04 | 214.24 | 231.98 |
Corneal Health Corneal Health Growth | 99 | 86.37 | 80.21 | 77.67 | 68.62 | 62.03 |
Revenue (Total) Revenue (Total) Growth | 612.84 | 507.44 | 383.48 | 314.71 | 282.86 | 294.01 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 286.23 | 278.76 | 318.92 | 295.43 | 352.7 | 414.05 |
Total Debt Total Debt Growth | 107.6 | 106.55 | 105.87 | 385.97 | 382.91 | 383.39 |
Net Cash (Debt) Net Cash Growth | 178.62 | 172.22 | 213.04 | -90.54 | -30.21 | 30.67 |
Net Cash Growth | 6.68% | -19.16% | - | - | - | -76.83% |
Net Cash Per Share Net Cash Per Share Growth | 3.08 | 3.01 | 4.04 | -1.87 | -0.64 | 0.66 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -0.95 | -14.79 | -61.32 | -57.76 | -33.08 | 24.71 |
Capital Expenditures CapEx Growth | -11.25 | -7.67 | -6.3 | -20.25 | -30.27 | -47.79 |
Free Cash Flow Free Cash Flow Growth | -12.2 | -22.46 | -67.62 | -78.01 | -63.35 | -23.08 |
Free Cash Flow Growth | - | - | - | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 79.12% | 77.96% | 75.48% | 75.99% | 75.61% | 77.34% |
Operating Margin | -12.89% | -17.09% | -28.20% | -39.31% | -36.17% | -17.98% |
Pretax Margin | -31.47% | -38.04% | -37.97% | -42.49% | -34.80% | -16.76% |
Profit Margin | -30.69% | -36.99% | -38.17% | -42.79% | -35.07% | -16.87% |
FCF Margin | -1.99% | -4.42% | -17.63% | -24.79% | -22.39% | -7.85% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 26, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Forward PE | 1276.09 | 167.80 | 167.80 | 167.80 | 167.80 | 167.80 |
PS Ratio | 17.13 | 12.77 | 21.55 | 12.32 | 7.36 | 7.08 |